Exenatide (Byetta®), a synthetic form of exendin-4 originally derived from the venom of the Gila monster (Heloderma suspectum), is a GLP-1 receptor agonist approved for the treatment of type 2 diabetes mellitus. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.